Christopher R. Ensor

2.4k total citations
65 papers, 1.1k citations indexed

About

Christopher R. Ensor is a scholar working on Surgery, Transplantation and Epidemiology. According to data from OpenAlex, Christopher R. Ensor has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 23 papers in Transplantation and 15 papers in Epidemiology. Recurrent topics in Christopher R. Ensor's work include Transplantation: Methods and Outcomes (30 papers), Renal Transplantation Outcomes and Treatments (21 papers) and Polyomavirus and related diseases (9 papers). Christopher R. Ensor is often cited by papers focused on Transplantation: Methods and Outcomes (30 papers), Renal Transplantation Outcomes and Treatments (21 papers) and Polyomavirus and related diseases (9 papers). Christopher R. Ensor collaborates with scholars based in United States, Australia and Switzerland. Christopher R. Ensor's co-authors include John F. McDyer, Adriana Zeevi, Matthew R. Morrell, Joseph M. Pilewski, Carlo J. Iasella, M. Shullo, Lauren M. Hynicka, Norihisa Shigemura, Matthew R. Pipeling and Jonathan D’Cunha and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Antimicrobial Agents and Chemotherapy and Plastic & Reconstructive Surgery.

In The Last Decade

Christopher R. Ensor

64 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher R. Ensor United States	19	565	414	218	177	151	65	1.1k
J. Foutz United States	9	940 1.7×	674 1.6×	64 0.3×	265 1.5×	186 1.2×	15	1.6k
Maite Rivera Spain	20	413 0.7×	278 0.7×	97 0.4×	250 1.4×	253 1.7×	126	1.5k
James E. Cooper United States	17	341 0.6×	593 1.4×	39 0.2×	115 0.6×	87 0.6×	22	905
Joshua J. Augustine United States	26	705 1.2×	1.1k 2.6×	54 0.2×	392 2.2×	282 1.9×	69	2.1k
Alihan Gürkan Türkiye	17	368 0.7×	218 0.5×	58 0.3×	102 0.6×	205 1.4×	72	780
María José Pérez‐Sáez Spain	20	485 0.9×	691 1.7×	20 0.1×	177 1.0×	207 1.4×	110	1.4k
Vassilis G. Hadjianastassiou United Kingdom	14	327 0.6×	224 0.5×	123 0.6×	95 0.5×	157 1.0×	29	708
Ruth Sapir‐Pichhadze Canada	19	439 0.8×	738 1.8×	49 0.2×	114 0.6×	94 0.6×	76	1.1k
Shambhu Aryal United States	14	168 0.3×	86 0.2×	58 0.3×	120 0.7×	476 3.2×	65	789
Eric D. Wolff Netherlands	20	220 0.4×	167 0.4×	169 0.8×	88 0.5×	280 1.9×	38	1.4k

Countries citing papers authored by Christopher R. Ensor

Since Specialization

Citations

This map shows the geographic impact of Christopher R. Ensor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Ensor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Ensor more than expected).

Fields of papers citing papers by Christopher R. Ensor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Ensor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Ensor. The network helps show where Christopher R. Ensor may publish in the future.

Co-authorship network of co-authors of Christopher R. Ensor

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Ensor. A scholar is included among the top collaborators of Christopher R. Ensor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Ensor. Christopher R. Ensor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Paul, Jeffrey J. Teuteberg, Kiran K. Khush, et al.. (2025). Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection. JACC Heart Failure. 14(1). 102716–102716. 1 indexed citations

Iasella, Carlo J., Christopher R. Ensor, Marilyn Marrari, et al.. (2020). Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation. 39(12). 1417–1425. 23 indexed citations

Iasella, Carlo J., Spencer Winters, Jaehee Cho, et al.. (2019). Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. American Journal of Transplantation. 20(5). 1439–1446. 9 indexed citations

Coons, James C., Neal Benedict, Amy L. Seybert, et al.. (2019). A Pharmacotherapy Scholars Program to Provide Intensive Training to Enhance Pharmacy Students’ Postgraduate Readiness. American Journal of Pharmaceutical Education. 83(9). 7327–7327. 7 indexed citations

Ensor, Christopher R., et al.. (2019). Discharge medication procurement and education after kidney transplantation. Clinical Transplantation. 33(8). e13627–e13627. 4 indexed citations

Popescu, Iulia, H. Mannem, Spencer Winters, et al.. (2018). Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres. American Journal of Respiratory and Critical Care Medicine. 199(3). 362–376. 68 indexed citations

Iasella, Carlo J., et al.. (2018). Cytokine-targeted therapy for the management of solid organ transplant recipients. Human Immunology. 80(3). 184–190. 5 indexed citations

Ensor, Christopher R., Carlo J. Iasella, Matthew R. Morrell, et al.. (2018). Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients. American Journal of Transplantation. 18(6). 1527–1533. 39 indexed citations

Lendermon, Elizabeth A., Tiffany A. Coon, X. Wang, et al.. (2018). Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet-/- Mouse Lung Allograft Recipients. Transplantation Proceedings. 50(5). 1566–1574. 1 indexed citations

10.

Rivosecchi, Ryan, Cornelius J. Clancy, Ryan K. Shields, et al.. (2017). Effects of Isavuconazole on the Plasma Concentrations of Tacrolimus among Solid-Organ Transplant Patients. Antimicrobial Agents and Chemotherapy. 61(9). 40 indexed citations

11.

Iasella, Carlo J., B. A. Johnson, Matthew R. Morrell, et al.. (2017). Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors. Transplantation. 102(1). 171–177. 39 indexed citations

12.

Reinsmoen, Nancy L., James Mirocha, Christopher R. Ensor, et al.. (2016). A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome. Transplantation. 101(6). 1215–1221. 51 indexed citations

13.

Streiff, Michael B., et al.. (2014). Pharmacist-Managed International Normalized Ratio Patient Self-Testing Is Associated with Increased Time in Therapeutic Range in Patients with Left Ventricular Assist Devices at an Academic Medical Center. ASAIO Journal. 60(2). 193–198. 37 indexed citations

14.

Morrell, Matthew R., Joseph M. Pilewski, Cynthia Gries, et al.. (2014). De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. The Journal of Heart and Lung Transplantation. 33(12). 1288–1294. 126 indexed citations

15.

Ensor, Christopher R. & Christina T. Doligalski. (2012). Proliferation signal inhibitor toxicities after thoracic transplantation. Expert Opinion on Drug Metabolism & Toxicology. 9(1). 63–77. 10 indexed citations

16.

Ensor, Christopher R., Roy Sabo, & Stacy A. Voils. (2011). Impact of Early Postoperative Hydrocortisone Administration in Cardiac Surgical Patients after Cardiopulmonary Bypass. Annals of Pharmacotherapy. 45(2). 189–194. 10 indexed citations

17.

Ensor, Christopher R., et al.. (2011). Generic Maintenance Immunosuppression in Solid Organ Transplant Recipients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(11). 1111–1129. 40 indexed citations

18.

Kraus, Peggy S., Christopher R. Ensor, Todd Nesbit, et al.. (2011). Development and implementation of a pharmacist-managed inpatient anticoagulation monitoring program. American Journal of Health-System Pharmacy. 68(10). 934–939. 6 indexed citations

19.

Ensor, Christopher R. & Stuart D. Russell. (2010). Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure. Expert Opinion on Pharmacotherapy. 11(14). 2405–2415. 6 indexed citations

20.

Ensor, Christopher R., et al.. (1955). Some aspects of the pathology, aetiology, and therapeutics of foot-rot in pigs. New Zealand Veterinary Journal. 3(3). 91–99. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact